ARCHIVES

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

This article is from The Cancer Letter archive.

Vol. 28 No. 16 | April 19, 2002

Download PDF Visit The Full Archive

Related Articles

Erin Fox: Shortages to Continue for 4-6 Years

October 11, 2013

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000

Animal Diagnostic Lab concept OK’d

February 18, 1994

Karlan To Succeed Hoskins As Chairman, DOD Ovarian Cancer Program Advisory Panel.

July 27, 2001

In Brief: Li, Gart Retire Forom NCI; Clifford Heads Diet Branch; ASTRO Meeting Nov. 4-8 In Washington

October 18, 1991

Decision To Stop NSABP P-4 Study Before It Starts Shocks Clinical Trialists.

March 2, 2007